カテゴリ： visiongain, 世界, 医療/バイオ

感染症診断のグローバル市場2022-2032：機器、試薬・キット・消耗品、ソフトウェア・サービス

■ 英語タイトル：Infectious Disease Diagnostics Market Report 2022-2032 : Forecasts by Product (Instrument, Reagents, Kits, & Consumables, Software & Services), by Type of Testing (Laboratory Testing and POC Testing), by Technology (Immunodiagnostics, Polymerase Chain Reaction (PCR), DNA Sequencing And Next-Generation Sequencing (NGS), Clinical Microbiology, Other), by Application (COVID-19, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Hepatitis, Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other), by End-user (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Home Care Settings, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

調査会社visiongain社が発行したリサーチレポート（データ管理コード：VGA23FB008）■ 発行会社/調査会社：visiongain
■ 商品コード：VGA23FB008
■ 発行日：2022年12月16日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：325
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Sigle User（1名様閲覧用、1年間、印刷不可）GBP3,950 ⇒換算￥750,500見積依頼/購入/質問フォーム
Enterprise（法人閲覧用、1年間、印刷可）GBP6,950 ⇒換算￥1,320,500見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM（デジタル著作権管理）付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[感染症診断のグローバル市場2022-2032：機器、試薬・キット・消耗品、ソフトウェア・サービス]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Visiongain社の本調査資料は、世界の感染症診断市場規模が2032年までにCAGR 6.61%で成長すると推測しています。本資料は、感染症診断の世界市場について幅広く調査を行い、レポート概要、エグゼクティブサマリー、市場動向、製品別（機器、試薬・キット・消耗品、ソフトウェア・サービス）分析、検査種類別（ラボ検査、POC検査）分析、技術別（免疫診断、ポリメラーゼ連鎖反応（PCR）、DNA シーケンシング＆次世代シーケンシング（NGS）、臨床微生物、その他）分析、用途別（新型コロナ感染症、HIV、HAI、HPV、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、企業情報など、以下のようにまとめています。尚、Abbott Laboratories、Becton, Dickinson and Company、Bio-Rad Laboratories、BioMérieux SA、Danaher Corporation、F. Hoffmann-La Roche Ltd、PerkinElmer Inc.、Quidel Corporation. 、Siemens Healthineers、Thermo Fisher Scientificなどの企業情報を含んでいます。
・レポート概要
・エグゼクティブサマリー
・市場動向
・世界の感染症診断市場規模：製品別
- 機器の市場規模
- 試薬・キット・消耗品の市場規模
- ソフトウェア・サービスの市場規模
・世界の感染症診断市場規模：検査種類別
- ラボ検査の市場規模
- POC検査の市場規模
・世界の感染症診断市場規模：技術別
- 免疫診断の市場規模
- ポリメラーゼ連鎖反応（PCR）の市場規模
- DNA シーケンシング＆次世代シーケンシング（NGS）の市場規模
- 臨床微生物の市場規模
- その他技術の市場規模
・世界の感染症診断市場規模：用途別
- 新型コロナ感染症診断の市場規模
- HIV診断の市場規模
- HAI診断の市場規模
- HPV診断の市場規模
- その他用途の市場規模
・世界の感染症診断市場規模：地域別
- 北米の感染症診断市場規模
- ヨーロッパの感染症診断市場規模
- アジア太平洋の感染症診断市場規模
- 中南米の感染症診断市場規模
- 中東・アフリカの感染症診断市場規模
・企業情報

The Infectious Disease Diagnostics Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Prevalence of Infectious Diseases, And Shift in Focus from Centralized Laboratories to Decentralized POC Testing Are Driving the Market Growth
Growing prevalence of infectious diseases is anticipated to drive the growth of the infectious disease diagnostics market over the forecast period. For instance, on February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases of coronavirus disease 2019 in locations outside mainland China and the number of associated deaths was 2,462.

According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), 37.7 million individuals were HIV positive in 2020, out of which 36 million were adults and 1.7 million were children between the ages of 0 and 14. Furthermore, more than half (53%) were females. 1.5 million new HIV cases were recorded in 2020 worldwide. Further, Hepatitis is a viral infection that results in liver inflammation. Hepatitis viruses come in five primary strains: A, B, C, D, and E. As per the World Health Organization (WHO), about 58 million individuals worldwide have chronic hepatitis C virus infection, and 1.5 million new infections occur each year.

According to WHO, After COVID-19, tuberculosis (TB) is the second most common infectious disease in the world and the thirteenth leading cause of death overall. As per WHO, 1.5 million deaths were caused due to TB in 2020 (including 214,000 people affected by HIV). WHO anticipated that 10 million individuals, including 1.1 million children, 3.3 million women, and 5.6 million men, would be affected by TB worldwide in 2020. All countries and age ranges are affected by TB. In addition, 30 countries with heavy TB burdens accounted for 86% of new TB cases in 2020. Two-thirds of the total is made up of eight countries, with India topping the list, then China, the Philippines, Nigeria, Pakistan, Indonesia, Bangladesh, and South Africa.

Moreover, the growing prevalence of healthcare-acquired infections (HAIs) globally. For instance, according to the Centers for Disease Control (CDC), HAIs alone in American hospitals are considered to be responsible for 1.7 million infections and 99,000 associated deaths per year. Of these infections, urinary tract infections make up 32% of all healthcare-acquired infections, followed by surgical site infections (22%), pneumonia (15%), and bloodstream infections (14%).

Growing prevalence of infectious diseases in developed and emerging nations will positively impact the growth of the infectious disease diagnostics market. The diagnosis and management of these diseases are key responsible factors for the rising number of prescriptions for diagnostic tests for infectious diseases. Large-scale population-based diagnostic testing is required for the prevention and control measures of COVID-19.

What Questions Should You Ask before Buying a Market Research Report?
• How is the infectious disease diagnostics market evolving?
• What is driving and restraining the infectious disease diagnostics market?
• How will each infectious disease diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each infectious disease diagnostics submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading infectious disease diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the infectious disease diagnostics research projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of infectious disease diagnostics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the infectious disease diagnostics market?
• Where is the infectious disease diagnostics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Infectious Disease Diagnostics Market today, and over the next 10 years:
• Our 32-page report provides 120 tables and 201 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Infectious Disease Diagnostics Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising infectious disease diagnostics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product
• Instrument
• Reagents, Kits, and Consumables
• Software & Services

Type of Testing
• Laboratory Testing
• POC Testing

Technology
• Immunodiagnostics
• Polymerase Chain Reaction (PCR)
– Real-time PCR/qPCR
– Reverse Transcriptase PCR (RT-PCR)
– Multiplex PCR
– Others
• DNA Sequencing and Next-Generation Sequencing (NGS)
• Clinical Microbiology
• Other technologies

Application
• COVID-19
• Human Immunodeficiency Virus (HIV)
• Healthcare-Associated Infections (HAIs)
• Hepatitis
• Human Papillomavirus (HPV)
• Tuberculosis (TB)
• Influenza
• Other Infectious Diseases

Application
• Diagnostic Laboratories
• Hospitals & Clinics
• Research Institutes
• Home Care Settings
• Other End Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 19 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Infectious Disease Diagnostics Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott
• Alere Inc.
• BioMérieux SA
• Becton, Dickinson and Company
• Cepheid, Inc.
• Co-Diagnostics
• Chembio Diagnostic Systems
• Danaher Corporation
• DiaSorin S.p.A.
• ELITechGroup
• Epitope Diagnostics
• F. Hoffmann-La Roche
• Hologic, Inc.
• Grifols S.A.
• Genetic Signatures Ltd.
• InBios International
• Meridian Bioscience
• Ortho Clinical Diagnostics Holdings plc
• OraSure Technologies
• PerkinElmer Inc.
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific
• Trinity Biotech Plc.
• Trivitron Healthcare
• Uniogen Oy
• Vela Diagnostics
• Meril Life Sciences Pvt. Ltd
• Quidel Corporation.

Overall world revenue for Infectious Disease Diagnostics Market, 2022 to 2032 in terms of value the market will surpass US$ 29,940.3 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Infectious Disease Diagnostics Market, 2022 to 2032 report help you?
In summary, our 320+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Infectious Disease Diagnostics Market, 2022 to 2032 Market, with forecasts for type and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for five regional and 19 key national markets – See forecasts for the Infectious Disease Diagnostics Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Infectious Disease Diagnostics Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Infectious Disease Diagnostics Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Infectious Disease Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Prevalence of Infectious Diseases
3.2.1.2 Shift in Focus from Centralized Laboratories to Decentralized POC Testing
3.2.1.3 Increase in Funding from Private & Government Organizations for Diagnostic Service Center
3.2.2 Market Restraining Factors
3.2.2.1 Unfavourable Reimbursement Scenario
3.2.2.2 Shortage of Skilled Professionals
3.2.3 Market Opportunities
3.2.3.1 Growing opportunities in growing economies
3.2.3.2 Introduction of cost-effective and reliable test kits
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Infectious Disease Diagnostics Market Analysis by Product
4.1 Key Findings
4.2 Product Segment Growth Prospects
4.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
4.4 Instrument
4.4.1 Market Size by Region, 2022-2032 (US$ Million)
4.4.2 Market Share by Region, 2022 & 2032 (%)
4.5 Reagents, Kits, and Consumables
4.5.1 Market Size by Region, 2022-2032 (US$ Million)
4.5.2 Market Share by Region, 2022 & 2032 (%)
4.6 Software & Services
4.6.1 Market Size by Region, 2022-2032 (US$ Million)
4.6.2 Market Share by Region, 2022 & 2032 (%)

5 Infectious Disease Diagnostics Market Analysis by Type of Testing
5.1 Key Findings
5.2 Type of Testing Segment Growth Prospects
5.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
5.4 Laboratory Testing
5.4.1 Market Size by Region, 2022-2032 (US$ Million)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 POC Testing
5.5.1 Market Size by Region, 2022-2032 (US$ Million)
5.5.2 Market Share by Region, 2022 & 2032 (%)

6 Infectious Disease Diagnostics Market Analysis by Technology
6.1 Key Findings
6.2 Technology Segment Growth Prospects
6.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
6.4 Immunodiagnostics
6.4.1 Market Size by Region, 2022-2032 (US$ Million)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.6 Polymerase Chain Reaction (PCR)
6.6.1 Market Size by Region, 2022-2032 (US$ Million)
6.6.2 Market Share by Region, 2022 & 2032 (%)
6.7 DNA Sequencing and Next-Generation Sequencing (NGS)
6.7.1 Market Size by Region, 2022-2032 (US$ Million)
6.7.2 Market Share by Region, 2022 & 2032 (%)
6.8 Clinical Microbiology
6.8.1 Market Size by Region, 2022-2032 (US$ Million)
6.8.2 Market Share by Region, 2022 & 2032 (%)
6.9 Other technologies
6.9.1 Market Size by Region, 2022-2032 (US$ Million)
6.9.2 Market Share by Region, 2022 & 2032 (%)

7 Infectious Disease Diagnostics Market Analysis by Application
7.1 Key Findings
7.2 Application Segment Growth Prospects
7.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
7.4 COVID-19
7.4.1 Market Size by Region, 2022-2032 (US$ Million)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 Human Immunodeficiency Virus (HIV)
7.5.1 Market Size by Region, 2022-2032 (US$ Million)
7.5.2 Market Share by Region, 2022 & 2032 (%)
7.6 Healthcare-Associated Infections (HAIs)
7.6.2 Market Share by Region, 2022 & 2032 (%)
7.7 Hepatitis
7.7.1 Market Size by Region, 2022-2032 (US$ Million)
7.7.2 Market Share by Region, 2022 & 2032 (%)
7.8 Human Papillomavirus (HPV)
7.8.2 Market Share by Region, 2022 & 2032 (%)
7.9 Tuberculosis (TB)
7.9.1 Market Size by Region, 2022-2032 (US$ Million)
7.9.2 Market Share by Region, 2022 & 2032 (%)
7.10 Influenza
7.10.1 Market Size by Region, 2022-2032 (US$ Million)
7.10.2 Market Share by Region, 2022 & 2032 (%)
7.11 Other Infectious Diseases
7.11.1 Market Size by Region, 2022-2032 (US$ Million)
7.11.2 Market Share by Region, 2022 & 2032 (%)

8 Infectious Disease Diagnostics Market Analysis by End User
8.1 Key Findings
8.2 End User Segment Growth Prospects
8.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by End User
8.4 Diagnostic Laboratories
8.4.2 Market Share by Region, 2022 & 2032 (%)
8.5 Hospitals & Clinics
8.5.1 Market Size by Region, 2022-2032 (US$ Million)
8.5.2 Market Share by Region, 2022 & 2032 (%)
8.6 Research Institutes
8.6.1 Market Size by Region, 2022-2032 (US$ Million)
8.6.2 Market Share by Region, 2022 & 2032 (%)
8.7 Home Care Settings
8.7.1 Market Size by Region, 2022-2032 (US$ Million)
8.7.2 Market Share by Region, 2022 & 2032 (%)
8.8 Other End Users
8.8.1 Market Size by Region, 2022-2032 (US$ Million)
8.8.2 Market Share by Region, 2022 & 2032 (%)

9 Infectious Disease Diagnostics Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
9.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

10 North America Infectious Disease Diagnostics Market Analysis
10.1 Key Findings
10.2 North America Infectious Disease Diagnostics Market Attractiveness Index
10.3 North America Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
10.4 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
10.5 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
10.6 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
10.7 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
10.8 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
10.9 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by End users
10.10 U.S. Infectious Disease Diagnostics Market Analysis
10.11 Canada Infectious Disease Diagnostics Market Analysis

11 Europe Infectious Disease Diagnostics Market Analysis
11.1 Key Findings
11.2 Europe Infectious Disease Diagnostics Market Attractiveness Index
11.3 Europe Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
11.4 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
11.5 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
11.6 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
11.7 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
11.8 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
11.9 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by End User
11.10 Germany Infectious Disease Diagnostics Market Analysis
11.11 UK Infectious Disease Diagnostics Market Analysis
11.12 France Infectious Disease Diagnostics Market Analysis
11.12 Italy Infectious Disease Diagnostics Market Analysis
11.13 Spain Infectious Disease Diagnostics Market Analysis
11.14 Russia Infectious Disease Diagnostics Market Analysis
11.15 Rest of Europe Infectious Disease Diagnostics Market Analysis

12 Asia Pacific Infectious Disease Diagnostics Market Analysis
12.1 Key Findings
12.2 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Index
12.3 Asia Pacific Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
12.4 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
12.5 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
12.6 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
12.7 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
12.8 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
12.9 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
12.10 Japan Infectious Disease Diagnostics Market Analysis
12.11 China Infectious Disease Diagnostics Market Analysis
12.12 India Infectious Disease Diagnostics Market Analysis
12.13 Australia Infectious Disease Diagnostics Market Analysis
12.14 South Korea Infectious Disease Diagnostics Market Analysis
12.15 Rest of Asia Pacific Infectious Disease Diagnostics Market Analysis

13 Latin America Infectious Disease Diagnostics Market Analysis
13.1 Key Findings
13.2 Latin America Infectious Disease Diagnostics Market Attractiveness Index
13.3 Latin America Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
13.4 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
13.5 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
13.6 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
13.7 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
13.8 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
13.9 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
13.10 Brazil Infectious Disease Diagnostics Market Analysis
13.11 Mexico Infectious Disease Diagnostics Market Analysis
13.12 Rest of Latin America Infectious Disease Diagnostics Market Analysis

14 MEA Infectious Disease Diagnostics Market Analysis
14.1 Key Findings
14.2 MEA Infectious Disease Diagnostics Market Attractiveness Index
14.3 MEA Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
14.4 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
14.5 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
14.6 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
14.7 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
14.8 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
14.9 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
14.10 GCC Infectious Disease Diagnostics Market Analysis
14.11 South Africa Infectious Disease Diagnostics Market Analysis
14.12 Rest of MEA Infectious Disease Diagnostics Market Analysis

15 Company Profiles
15.1 Competitive Landscape, 2021
15.2 Danaher Corporation
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2017-2021
15.2.3.2 R&D, 2017-2021
15.2.3.3 Regional Market Shares, 2021
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 PerkinElmer Inc.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2021
15.3.3.2 R&D, 2017-2021
15.3.3.3 Regional Market Shares, 2021
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Abbott
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2017-2021
15.4.3.2 R&D, 2017-2021
15.4.3.3 Regional Market Shares, 2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 BioMérieux SA
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2017-2021
15.5.3.2 R&D, 2017-2021
15.5.3.3 Regional Market Shares, 2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 F. Hoffmann-La Roche Ltd
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2017-2021
15.6.3.2 R&D, 2017-2021
15.6.3.3 Regional Market Shares, 2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Becton, Dickinson and Company
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2017-2021
15.7.3.2 R&D, 2017-2021
15.7.3.3 Regional Market Shares, 2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Bio-Rad Laboratories
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2017-2021
15.8.3.2 R&D, 2017-2021
15.8.3.3 Regional Market Shares, 2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Siemens Healthineers
15.9.1 Company Snapshot
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2017-2021
15.9.3.2 R&D, 2017-2021
15.9.3.3 Regional Market Shares, 2021
15.9.4 Product Benchmarking
15.9.4 Strategic Outlook
15.10 Thermo Fisher Scientific
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2017-2021
15.10.3.2 R&D, 2017-2021
15.10.3.3 Regional Market Shares, 2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Quidel Corporation
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2017-2021
15.11.3.2 R&D, 2017-2021
15.11.3.3 Regional Market Shares, 2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from
16.2 Recommendations for Market Players



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 細胞解析のグローバル市場（2023-2032）：消耗品、サービス、機器、ソフトウェア
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(VGA23FB008 )"感染症診断のグローバル市場2022-2032：機器、試薬・キット・消耗品、ソフトウェア・サービス" (英文：Infectious Disease Diagnostics Market Report 2022-2032 : Forecasts by Product (Instrument, Reagents, Kits, & Consumables, Software & Services), by Type of Testing (Laboratory Testing and POC Testing), by Technology (Immunodiagnostics, Polymerase Chain Reaction (PCR), DNA Sequencing And Next-Generation Sequencing (NGS), Clinical Microbiology, Other), by Application (COVID-19, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Hepatitis, Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other), by End-user (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Home Care Settings, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis)はvisiongain社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。